TY - JOUR TI - Characterization of the ascending colon fluids in ulcerative colitis AU - Vertzoni, M. AU - Goumas, K. AU - Söderlind, E. AU - Abrahamsson, B. AU - Dressman, J.B. AU - Poulou, A. AU - Reppas, C. JO - Pharmaceutical Research PY - 2010 VL - 27 TODO - 8 SP - 1620-1626 PB - SN - 0724-8741, 1573-904X TODO - 10.1007/s11095-010-0158-y TODO - azathioprine; baclofen; bile acid; carbohydrate derivative; cholesterol; diacylglycerol; enema; isobutyric acid; long chain fatty acid; mesalazine; monoacylglycerol; pantoprazole; phosphatidylcholine; prednisolone; protein; short chain fatty acid; tizanidine; triacylglycerol; cholesterol; fatty acid; phosphatidylcholine, adult; article; ascending colon; clinical article; colonoscopy; controlled study; disease severity; drug efficacy; drug release; drug targeting; female; human; intestine fluid; male; osmolarity; pH; prediction; priority journal; relapse; remission; ulcerative colitis; adolescent; ascending colon; chemistry; middle aged; pathology; recurrent disease; solubility; stomach juice; ulcerative colitis; young adult, Adolescent; Adult; Cholesterol; Colitis, Ulcerative; Colon, Ascending; Fatty Acids; Female; Gastrointestinal Contents; Humans; Hydrogen-Ion Concentration; Male; Middle Aged; Phosphatidylcholines; Recurrence; Solubility; Young Adult, Adolescent; Adult; Cholesterol; Colitis, Ulcerative; Colon, Ascending; Fatty Acids; Female; Gastrointestinal Contents; Humans; Hydrogen-Ion Concentration; Male; Middle Aged; Phosphatidylcholines; Recurrence; Solubility; Young Adult TODO - Purpose: To characterize the fluid composition in ascending colon of fasted adults with ulcerative colitis in relapse and in remission with a view to predicting variations on dosage form performance in the lower inflamed gut. Methods: Twelve patients participated in a two-phase, crossover study. Enrolment to the relapse phase (Phase A) and designation of the remission state for the second colonoscopy (Phase B) were based on Clinical Rachmilewicz Index values. Samples were analyzed for pH and buffer capacity immediately upon collection. After ultracentrifugation, osmolality, surface tension, soluble protein, soluble carbohydrates, and the levels of ten bile acids, seven short-chain fatty acids (SCFAs), three long-chain fatty acids, triglycerides, diglycerides, monoglycerides, phosphatidylcholine, and cholesterol were measured. Results: Total SCFAs are significantly decreased in relapse, but pH remains unaffected. Regardless of remission/relapse status, pH and isobutyric acid levels are lower than in healthy adults. Buffer capacity, osmolality, and soluble protein are higher than in healthy adults. Treatment with prednisolone increases the volume of intracolonic contents. Conclusion: Variations in fluid composition of the ascending colon with activity and severity of ulcerative colitis may have an impact on the performance of orally administered products that are targeted to release the therapeutic agent in the colon. © 2010 Springer Science+Business Media, LLC. ER -